151 related articles for article (PubMed ID: 11829539)
1. Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state.
Witte K; Jacke K; Stahrenberg R; Arlt G; Reitenbach I; Schilling L; Lemmer B
Nitric Oxide; 2002 Feb; 6(1):85-95. PubMed ID: 11829539
[TBL] [Abstract][Full Text] [Related]
2. Effects of the endothelin a receptor antagonist darusentan on blood pressure and vascular contractility in type 2 diabetic Goto-Kakizaki rats.
Witte K; Reitenbach I; Stolpe K; Schilling L; Kirchengast M; Lemmer B
J Cardiovasc Pharmacol; 2003 Jun; 41(6):890-6. PubMed ID: 12775966
[TBL] [Abstract][Full Text] [Related]
3. The cardiovascular effects of salidroside in the Goto-Kakizaki diabetic rat model.
Alameddine A; Fajloun Z; Bourreau J; Gauquelin-Koch G; Yuan M; Gauguier D; Derbre S; Ayer A; Custaud MA; Navasiolava N
J Physiol Pharmacol; 2015 Apr; 66(2):249-57. PubMed ID: 25903955
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin II receptor antagonist on impaired endothelium-dependent and endothelium-independent relaxations in type II diabetic rats.
Oniki H; Fujii K; Kansui Y; Goto K; Iida M
J Hypertens; 2006 Feb; 24(2):331-8. PubMed ID: 16508581
[TBL] [Abstract][Full Text] [Related]
5. Contribution of Rho kinase to blood pressure elevation and vasoconstrictor responsiveness in type 2 diabetic Goto-Kakizaki rats.
Rao MY; Soliman H; Bankar G; Lin G; MacLeod KM
J Hypertens; 2013 Jun; 31(6):1160-9. PubMed ID: 23552123
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Van de Voorde J; Rasch R; Lameire NH; Flyvbjerg A
Nephrol Dial Transplant; 2004 May; 19(5):1092-7. PubMed ID: 14993490
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats.
Cheng ZJ; Vaskonen T; Tikkanen I; Nurminen K; Ruskoaho H; Vapaatalo H; Muller D; Park JK; Luft FC; Mervaala EM
Hypertension; 2001 Feb; 37(2 Pt 2):433-9. PubMed ID: 11230314
[TBL] [Abstract][Full Text] [Related]
8. Contribution of the nitric oxide-guanylyl cyclase system to circadian regulation of blood pressure in normotensive Wistar-Kyoto rats.
Witte K; Schnecko A; Zuther P; Lemmer B
Cardiovasc Res; 1995 Nov; 30(5):682-8. PubMed ID: 8595613
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of lower urinary tract dysfunction and bladder afferent nerve properties in type 2 diabetic goto-kakizaki rats.
Aizawa N; Homma Y; Igawa Y
J Urol; 2013 Apr; 189(4):1580-7. PubMed ID: 23103236
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
11. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase.
Klöss S; Bouloumié A; Mülsch A
Hypertension; 2000 Jan; 35(1 Pt 1):43-7. PubMed ID: 10642273
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
Matsumoto T; Ishida K; Taguchi K; Kobayashi T; Kamata K
Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological properties, functional alterations and gene expression of muscarinic receptors in young and old type 2 Goto-Kakizaki diabetic rat bladders.
Saito M; Okada S; Kazuyama E; Satoh I; Kinoshita Y; Satoh K
J Urol; 2008 Dec; 180(6):2701-5. PubMed ID: 18951563
[TBL] [Abstract][Full Text] [Related]
14. Involvement of CaM kinase II in the impairment of endothelial function and eNOS activity in aortas of Type 2 diabetic rats.
Kobayashi T; Nemoto S; Ishida K; Taguchi K; Matsumoto T; Kamata K
Clin Sci (Lond); 2012 Sep; 123(6):375-86. PubMed ID: 22494112
[TBL] [Abstract][Full Text] [Related]
15. Mild type 2 diabetes mellitus improves remote endothelial dysfunction after acute myocardial infarction.
Korkmaz-Icöz S; Vater A; Li S; Lehner A; Radovits T; Hegedűs P; Ruppert M; Brlecic P; Zorn M; Karck M; Szabó G
J Diabetes Complications; 2015; 29(8):1253-60. PubMed ID: 26219999
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
[TBL] [Abstract][Full Text] [Related]
17. Abnormal myosin phosphatase targeting subunit 1 phosphorylation and actin polymerization contribute to impaired myogenic regulation of cerebral arterial diameter in the type 2 diabetic Goto-Kakizaki rat.
Abd-Elrahman KS; Colinas O; Walsh EJ; Zhu HL; Campbell CM; Walsh MP; Cole WC
J Cereb Blood Flow Metab; 2017 Jan; 37(1):227-240. PubMed ID: 26721393
[TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction in the early- and late-stage type-2 diabetic Goto-Kakizaki rat aorta.
Kazuyama E; Saito M; Kinoshita Y; Satoh I; Dimitriadis F; Satoh K
Mol Cell Biochem; 2009 Dec; 332(1-2):95-102. PubMed ID: 19543853
[TBL] [Abstract][Full Text] [Related]
19. Augmented dilation to nitric oxide in uterine arteries from rats with type 2 diabetes: implications for vascular adaptations to pregnancy.
Goulopoulou S; Hannan JL; Matsumoto T; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H610-8. PubMed ID: 24337459
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent impairments to cerebral vascular reactivity with type 2 diabetes mellitus in the Goto-Kakizaki rat.
Halvorson BD; Whitehead SN; McGuire JJ; Wiseman RW; Frisbee JC
Am J Physiol Regul Integr Comp Physiol; 2019 Jul; 317(1):R149-R159. PubMed ID: 31091154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
